Essential Ways to Run a Python Script Python is one of the most popular programming languages today, widely praised for its simplicity and versatility. Whether you’re a beginner dipping your toes into ...

Over 100 NPM and PyPI packages were injected with malicious code in the Miasma and Hades Shai-Hulud supply chain attack ...

The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...

Claude now authors 80% of Anthropic's production code. The company's new paper maps the path to recursive self-improvement and calls for a global pause mechanism.

Mr. Bannon is the chief librarian of the New York Public Library, where he is also the director of branch libraries and education. See more of our coverage in your search results.Encuentra más de ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Read along with the Book Review this summer: Can you check off five items before fall arrives? (This year, there are prizes!) By The New York Times Books Staff Welcome, dear readers, to our second ...

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

This vibe coding cheat sheet explains how plain-language prompts can build apps fast, plus the planning, testing, and security checks needed. Software development is undergoing a seismic shift as vibe ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

City residents must take primary responsibility for the conditions of their properties and neighborhoods, Reading’s community development director says. “Your constituents have the primary ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...